Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of noncoding RNAs in metabolic reprogramming of cancer cells. | Cell Mol Biol Lett | 2023 | 37161350 | PubTator, text mining | PubMed |
| Thermal inkjet bioprinting drastically alters cell phenotype. | Biofabrication | 2023 | 37160133 | PubTator, text mining | PubMed |
| Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis. | Int J Biol Sci | 2023 | 37151889 | PubTator, text mining | PubMed |
| Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review. | Cancer Med | 2023 | 37132286 | PubTator, text mining | PubMed |
| Correction: Clinical and genetic analysis further delineates the phenotypic spectrum of ALDH1A3-related anophthalmia and microphthalmia. | Eur J Hum Genet | 2023 | 37106145 | PubTator, text mining | PubMed |
| Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer. | Int J Biol Sci | 2023 | 37063424 | PubTator, text mining | PubMed |
| RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma. | Int J Mol Sci | 2023 | 37047826 | PubTator, text mining | PubMed |
| A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment. | Int J Mol Sci | 2023 | 37047661 | PubTator, text mining | PubMed |
| Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37046721 | PubTator, text mining | PubMed |
| PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer. | Nat Commun | 2023 | 37024475 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| The tumor-nerve circuit in breast cancer. | Cancer Metastasis Rev | 2023 | 36997828 | PubTator, text mining | PubMed |
| Clinical and genetic analysis further delineates the phenotypic spectrum of ALDH1A3-related anophthalmia and microphthalmia. | Eur J Hum Genet | 2023 | 36997679 | PubTator, text mining | PubMed |
| MiR-320b aberrant expression enhances the radioresistance of human glioma via upregulated expression of ALDH1A3. | Aging (Albany NY) | 2023 | 36996494 | PubTator, text mining | PubMed |
| KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe. | Int J Mol Sci | 2023 | 36982384 | PubTator, text mining | PubMed |
| EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis. | Genes (Basel) | 2023 | 36980923 | PubTator, text mining | PubMed |
| A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives. | Cells | 2023 | 36980246 | PubTator, text mining | PubMed |
| Undernutrition Disrupts Cecal Microbiota and Epithelium Interactions, Epithelial Metabolism, and Immune Responses in a Pregnant Sheep Model. | Microbiol Spectr | 2023 | 36976022 | PubTator, text mining | PubMed |
| In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin. | Curr Issues Mol Biol | 2023 | 36975509 | PubTator, text mining | PubMed |
| Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. | iScience | 2023 | 36968082 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=14